Global Migraine Drugs Market: Insights and Forecast with Potential Impact of COVID-19 (2019-2025)


Posted July 8, 2021 by market-sdkiblogs

The global migraine market is expected to reach US$5.10 billion in 2024, growing at a CAGR of 3.7%, for the duration spanning 2020-2024.

 
The global migraine market is expected to reach US$5.10 billion in 2024, growing at a CAGR of 3.7%, for the duration spanning 2020-2024.

The factors such as growing female population, increasing cigarette consumption, increasing pharmaceutical R&D expenditures, accelerating economic growth, increasing healthcare spending, increasing stress levels, unmet medical needs and prevalence of migraine at high rates would drive the growth of the market.

Fill This Form and get the Sample Copy of This Report: https://www.sdki.jp/sample-request-58870


"The Final Report will cover the impact analysis of COVID-19 on this industry (Global Migraine Drugs Market)."

However, the market growth would be challenged by adverse effect of drugs, lack of proper diagnosis, increased preferences for alternative options, regulatory challenges and high cost associated.

A few notable trends include, growth in pharmaceutical & biotech merger & acquisition, progressing CGRP targeting drug pipeline, branded acute treatment for episodic migraine, growing awareness regarding migraine and its therapeutics and development of additional migraine therapeutics.

Fill This Form and get the Sample Copy of This Report: https://www.sdki.jp/sample-request-58870


"The Final Report will cover the impact analysis of COVID-19 on this industry (Global Migraine Drugs Market)."

Further, the sudden outbreak of COVID-19, would trigger the stress levels among people, due to the implementation of the lockdown measures, which would elevate the risk of migraine among them and thereby is expected to accelerate the growth of the global migraine market in coming years.

Scope of the report:
The report provides a comprehensive analysis of the global monoclonal antibodies market.
The major regional markets (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) have been analyzed.
The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
The competitive landscape of the market, along with the company profiles of leading players (Johnson & Johnson, Novartis AG, Merck & Co., AbbVie Inc., Bristol-Myer Squibb and Amgen AG) are also presented in detail.
Key Target Audience:
Monoclonal Antibodies Manufacturers
Pharmaceuticals and Biopharmaceutical Firms
End Users (Hospitals and Research Institutes)
Investment Banks
Healthcare and Medical Consultants
Government Bodies & Regulating Authorities

+ Table of content +

1. Overview
1.1 Migraine
1.2 Types of Migraine
1.3 Stages of Migraine
1.4 Diagnosis Procedures
1.5 Migraine Treatment
1.6 CGRP – A New Era of Migraine Treatment
2. Impact of COVID-19
2.1 Rise in Stress Level
2.2 Growth in Government Spending on Healthcare
2.3 Increase in Alcohol Consumption
2.4 Impact of Excessive Use of Hand Sanitizers
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By SDKI Blog | Market News and Opportunities
Country India
Categories Blogging , Health , Marketing
Last Updated July 8, 2021